Compare
Amgen vs Regeneron Pharmaceuticals (AMGN vs REGN)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Amgen (AMGN) returned +43.9% and Regeneron Pharmaceuticals (REGN) +40.4%; so far this year the figures are +40.7% and +17.2%.
Amgen is the larger company by market value, about 2.6 times the size of Regeneron Pharmaceuticals.
On trailing earnings, AMGN trades at 26.7 times and REGN at 20.0 times.
Revenue grew +8.2% at AMGN and +18.6% at REGN over the last year.
AMGN yields 2.16%. REGN yields 0.41%.
Data as of the latest close. Not investment advice.
Relative performance
| AMGN | REGN | |
|---|---|---|
| Price | $460.42 | $904.35 |
| 1-day | +0.03% | +0.16% |
| YTD | +40.67% | +17.16% |
| 1 year | +43.94% | +40.39% |
| 3 years | +76.51% | +14.29% |
| Market cap | $249.1B | $95.5B |
| P/E | 26.7 | 20.0 |
| P/S | 6.40 | 5.65 |
| P/B | 17.35 | 2.85 |
| Revenue growth | +8.20% | +18.60% |
| EPS growth | +33.30% | +8.30% |
| Gross margin % | 70.9 | 36.4 |
| Net margin % | 24.1 | 28.5 |
| ROE % | 65.4 | 14.4 |
| Debt / equity | 3.76 | 0.10 |
| FCF yield % | 3.8 | 4.0 |
| Dividend yield % | 2.16 | 0.41 |
| Beta | 0.50 | 0.29 |
| RSI (14) | 60.5 | 63.1 |
| Technical rating |